Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications

被引:12
作者
Cong, Yating [1 ]
Li, Na [1 ,2 ]
Zhang, Zixin [1 ]
Shang, Yan [1 ]
Zhao, Hailong [1 ]
机构
[1] Zunyi Med Univ, Dept Pathophysiol, Zunyi 563000, Guizhou, Peoples R China
[2] Zunyi Med Univ, Clin Inst 1, Zunyi 563000, Guizhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Cuproptosis; Copper metabolism; Cancer prognosis; Immunotherapy; COPPER; DISEASE; LIPT1; NANOPARTICLES; NECROPTOSIS; GENERATION;
D O I
10.1186/s12967-025-06121-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cuproptosis differs from other forms of cell death, such as apoptosis, necroptosis, and ferroptosis, in its unique molecular mechanisms and signaling pathways. In this review, we delve into the cellular metabolic pathways of copper, highlighting the role of copper in biomolecule synthesis, mitochondrial respiration, and antioxidant defense. Furthermore, we elucidate the relationship between cuproptosis-related genes (CRGs) and cancer prognosis, analyzing their expression patterns across various tumor types and their impact on patient outcomes. Our review also uncovers the potential therapeutic applications of copper chelators, copper ionophores, and copper-based nanomaterials in oncology. In addition, we discuss the emerging role of cuproptosis in remodeling the tumor microenvironment, enhancing immune cell infiltration, and converting "cold tumors" into "hot tumors" that respond better to immunotherapy. In short, this review underscores the pivotal importance of cuproptosis in cancer biology and highlights its translational potential as a novel therapeutic target.
引用
收藏
页数:17
相关论文
共 131 条
[1]   Yeast Cox17 solution structure and copper(I) binding [J].
Abajian, C ;
Yatsunyk, LA ;
Ramirez, BE ;
Rosenzweig, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) :53584-53592
[2]  
[Anonymous], 2023, BMC Pulm Med, V23, P205
[3]  
[Anonymous], 2022, Front cell Dev Biology, V10
[4]  
[Anonymous], 2023, Cell Res, V33, P263
[5]  
[Anonymous], 2022, J. Curr Opin Physiol, P25
[6]  
[Anonymous], 2022, Front Immunol, V13
[7]  
[Anonymous], 2022, Int. J. Mol. Sci., V23
[8]  
[Anonymous], 2021, Front cell Dev Biology, V9
[9]  
[Anonymous], 2023, Trends Mol Med, V29, P753
[10]  
[Anonymous], 2023, Front Oncol, V13